These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38374741)

  • 1. Who Benefited the Most? Effectiveness of a Lifestyle Intervention Against Cognitive Decline in Older Women and Men - Secondary Analysis of the AgeWell.de-trial.
    Wittmann FG; Pabst A; Zülke A; Luppa M; Blotenberg I; Cardona MI; Bauer A; Fuchs S; Zöllinger I; Sanftenberg L; Brettschneider C; Döhring J; Lunden L; Czock D; Wiese B; Thyrian JR; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Riedel-Heller SG
    J Prev Alzheimers Dis; 2024; 11(2):348-355. PubMed ID: 38374741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AgeWell.de - study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients.
    Zülke A; Luck T; Pabst A; Hoffmann W; Thyrian JR; Gensichen J; Kaduszkiewicz H; König HH; Haefeli WE; Czock D; Wiese B; Frese T; Röhr S; Riedel-Heller SG
    BMC Geriatr; 2019 Aug; 19(1):203. PubMed ID: 31370792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to a lifestyle intervention - just a question of self-efficacy? Analysis of the AgeWell.de-intervention against cognitive decline.
    Wittmann FG; Pabst A; Zülke A; Luppa M; Oey A; Boekholt M; Weise S; Fankhänel T; Kosilek RP; Brettschneider C; Döhring J; Lunden L; Wiese B; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Thyrian JR; Riedel-Heller SG
    Alzheimers Res Ther; 2024 Jun; 16(1):133. PubMed ID: 38909256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment and Baseline Characteristics of Participants in the AgeWell.de Study-A Pragmatic Cluster-Randomized Controlled Lifestyle Trial against Cognitive Decline.
    Röhr S; Zülke A; Luppa M; Brettschneider C; Weißenborn M; Kühne F; Zöllinger I; Samos FZ; Bauer A; Döhring J; Krebs-Hein K; Oey A; Czock D; Frese T; Gensichen J; Haefeli WE; Hoffmann W; Kaduszkiewicz H; König HH; Thyrian JR; Wiese B; Riedel-Heller SG
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33430189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multidomain intervention against cognitive decline in an at-risk-population in Germany: Results from the cluster-randomized AgeWell.de trial.
    Zülke AE; Pabst A; Luppa M; Roehr S; Seidling H; Oey A; Cardona MI; Blotenberg I; Bauer A; Weise S; Zöllinger I; Sanftenberg L; Brettschneider C; Döhring J; Lunden L; Czock D; Haefeli WE; Wiese B; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Thyrian JR; Riedel-Heller SG
    Alzheimers Dement; 2024 Jan; 20(1):615-628. PubMed ID: 37768074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age- and sex-specific effects of a long-term lifestyle intervention on body weight and cardiometabolic health markers in adults with prediabetes: results from the diabetes prevention study PREVIEW.
    Zhu R; Craciun I; Bernhards-Werge J; Jalo E; Poppitt SD; Silvestre MP; Huttunen-Lenz M; McNarry MA; Stratton G; Handjiev S; Handjieva-Darlenska T; Navas-Carretero S; Sundvall J; Adam TC; Drummen M; Simpson EJ; Macdonald IA; Brand-Miller J; Muirhead R; Lam T; Vestentoft PS; Færch K; Martinez JA; Fogelholm M; Raben A
    Diabetologia; 2022 Aug; 65(8):1262-1277. PubMed ID: 35610522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a multidomain intervention against cognitive decline on dementia risk profiles - Results from the AgeWell.de trial.
    Zülke AE; Pabst A; Luppa M; Oey A; Weise S; Fankhänel T; Kosilek RP; Schillok H; Brettschneider C; Czock D; Wiese B; Thyrian JR; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Riedel-Heller SG
    Alzheimers Dement; 2024 Aug; 20(8):5684-5694. PubMed ID: 38967275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment.
    McMaster M; Kim S; Clare L; Torres SJ; D'Este C; Anstey KJ
    Clin Interv Aging; 2018; 13():2397-2406. PubMed ID: 30538436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General practitioners' perspectives on lifestyle interventions for cognitive preservation in dementia prevention.
    Kappe J; Wittmann F; Luppa M; Cardona MI; Weise S; Fuchs S; Kosilek RP; Sanftenberg L; Brettschneider C; Döhring J; Escales C; Czock D; Wiese B; Thyrian JR; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Riedel-Heller SG
    BMC Prim Care; 2024 Aug; 25(1):301. PubMed ID: 39143540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-Specific Design and Effectiveness of Non-Pharmacological Interventions against Cognitive Decline - Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zülke AE; Riedel-Heller SG; Wittmann F; Pabst A; Röhr S; Luppa M
    J Prev Alzheimers Dis; 2023; 10(1):69-82. PubMed ID: 36641611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. China Initiative for Multi-Domain Intervention (CHINA-IN-MUDI) to Prevent Cognitive Decline: Study Design and Progress.
    Li SY; Xie XY; Liu D; Cheng GR; Hu FF; Zeng DY; Chen XC; Jia LF; Wang YJ; Bu XL; Qiu C; Gao F; Gu JG; Liu MF; Li Y; Zhou YL; Chang HJ; Ou YM; Xu L; Wu ZX; Zhang JJ; Wang JY; Huang LY; Cui YY; Zhou J; Liu XC; Liu J; Nie QQ; Song D; Cai C; Han GB; Yang X; Tan W; Yu JT; Zeng Y
    J Prev Alzheimers Dis; 2024; 11(3):589-600. PubMed ID: 38706275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life.
    Gates NJ; Rutjes AW; Di Nisio M; Karim S; Chong LY; March E; Martínez G; Vernooij RW
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012277. PubMed ID: 32104914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere Length Change in a Multidomain Lifestyle Intervention to Prevent Cognitive Decline: A Randomized Clinical Trial.
    Sindi S; Solomon A; Kåreholt I; Hovatta I; Antikainen R; Hänninen T; Levälahti E; Laatikainen T; Lehtisalo J; Lindström J; Paajanen T; Peltonen M; Singh Khalsa D; Wolozin B; Strandberg T; Tuomilehto J; Soininen H; Ngandu T; Kivipelto M;
    J Gerontol A Biol Sci Med Sci; 2021 Feb; 76(3):491-498. PubMed ID: 33175128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-domain interventions for the prevention of dementia and cognitive decline.
    Hafdi M; Hoevenaar-Blom MP; Richard E
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013572. PubMed ID: 34748207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in a high-risk group of elderly primary care patients: characteristics and potential for improvement.
    Döhring J; Williamson M; Brettschneider C; Fankhänel T; Luppa M; Pabst A; Weißenborn M; Zöllinger I; Czock D; Frese T; Gensichen J; Hoffmann W; König HH; Thyrian JR; Wiese B; Riedel-Heller S; Kaduszkiewicz H
    Qual Life Res; 2024 Jul; 33(7):1841-1851. PubMed ID: 38740640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Would older adults with mild cognitive impairment adhere to and benefit from a structured lifestyle activity intervention to enhance cognition?: a cluster randomized controlled trial.
    Lam LC; Chan WC; Leung T; Fung AW; Leung EM
    PLoS One; 2015; 10(3):e0118173. PubMed ID: 25826620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mediterranean Diet and Walking Intervention to Reduce Cognitive Decline and Dementia Risk in Independently Living Older Australians: The MedWalk Randomized Controlled Trial Experimental Protocol, Including COVID-19 Related Modifications and Baseline Characteristics.
    Pipingas A; Murphy KJ; Davis CR; Itsiopoulos C; Kingsley M; Scholey A; Macpherson H; Segal L; Breckon J; Minihane AM; Meyer D; Ogden E; Dyer KA; Eversteyn E; Hardman RJ; Poorun K; Justice K; Hana M; Buckley JD; White D; Davison K; Clark JS; Bracci EL; Kennedy G;
    J Alzheimers Dis; 2023; 96(1):409-427. PubMed ID: 37781806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrient intake and dietary changes during a 2-year multi-domain lifestyle intervention among older adults: secondary analysis of the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) randomised controlled trial.
    Lehtisalo J; Ngandu T; Valve P; Antikainen R; Laatikainen T; Strandberg T; Soininen H; Tuomilehto J; Kivipelto M; Lindström J
    Br J Nutr; 2017 Aug; 118(4):291-302. PubMed ID: 28875868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifiable dementia risk score to study heterogeneity in treatment effect of a dementia prevention trial: a post hoc analysis in the preDIVA trial using the LIBRA index.
    van Middelaar T; Hoevenaar-Blom MP; van Gool WA; Moll van Charante EP; van Dalen JW; Deckers K; Köhler S; Richard E
    Alzheimers Res Ther; 2018 Jun; 10(1):62. PubMed ID: 29960597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.